A Mild Panic? Media Accounts of Kratom

References

• Armstrong, Edward G. 2007. “Moral Panic over Meth.” Contemporary Justice Review 10 (4):427–42. doi: 10.1080/10282580701677519.
   Google Scholar
• Babu, Kavita M., Christopher. R. McCurdy, and Edward. W. Boyer. 2008. “Opioid Receptors and Legal Highs: Salvia Divinorum and Kratom.” Clinical Toxicology 46 (2):146–52. doi: 10.1080/15563650701241795.
   PubMed Web of Science ®Google Scholar
• Becker, Howard. 1963. Outsiders: Studies in the Sociology of Deviance. New York, NY: The Free Press.
   Google Scholar
• Borwein, Alexandra, Geroge Kephart, Emma Whelan, and Mark Asbridge. 2013. “Prescribing Practices amid the OxyContin Crisis: Examining the Effect of Print Media Coverage on Opioid Prescribing among Physicians.” The Journal of Pain 14 (12):1686–93. doi: 10.1016/j.jpain.2013.08.012.
   PubMed Web of Science ®Google Scholar
• Boyer, Edward W., Kavita M. Babu, Jessica E. Adkins, Christopher R. McCurdy, and John H. Halpern. 2008. “Self-Treatment of Opioid Withdrawal Using Kratom (Mitragynia Speciosa Korth).” Addiction 103 (6):1048–50. doi: 10.1111/j.1360-0443.2008.02209.x.
   PubMed Web of Science ®Google Scholar
• Cohen, Stanley. 1972. Folk Devils and Moral Panics: The Creation of the Mods and Rockers. Oxford: Martin Robertson.
   Google Scholar
• Cornwell, Benjamin and Annulla Linders. 2002. “The Myth of ‘Moral Panic’: An Alternative Account of LSD Prohibition.” Deviant Behavior 23 (4):307–30. doi: 10.1080/01639620290086404.
   Web of Science ®Google Scholar
• Critcher, Chas. 2003. Moral Panics and the Media. Buckingham, UK: Open University Press.
   Google Scholar
• Ferraiolo, Kathleen. 2007. “From Killer Weed to Popular Medicine: The Evolution of American Drug Control Policy, 1937–2000.” Journal of Policy History 19 (2):147–79. doi: 10.1353/jph.2007.0009.
   Google Scholar
• Glasser, Ira and Loren Siegel. 1997. “When Constitutional Rights Seem Too Extravagant to Endure: The Crack Scare’s Impact on Civil Rights and Liberties.” Pp. 229–48 in Crack in America: Demon Drugs and Social Justice, edited by C. Reinarman and H.G. Levine. Berkeley: University of California.
   Google Scholar
• Goode, Erich. 2008. “Moral Panics and Disproportionality: The Case of LSD Use in the Sixties.” Deviant Behavior 29 (6):533–43. doi: 10.1080/01639620701839377.
   Web of Science ®Google Scholar
• Goode, Erich. 2014. Drugs in American Society. 9th ed. New York, NY: McGraw-Hill.
   Google Scholar
• Goode, Erich and Nachman Ben-Yehuda. 1994. “Moral Panics: Culture, Politics, and Social Construction.” Annual Review of Sociology 20 (1):149–71. doi: 10.1146/annurev.so.20.080194.001053.
   Web of Science ®Google Scholar
• Griffin, O. Hayden. 2012. “Is the Government Keeping the Peace or Acting like Our Parents? Rationales for the Legal Prohibitions of GHB and MDMA.” Journal of Drug Issues 42 (3):247–62. doi: 10.1177/0022042612456014.
   Web of Science ®Google Scholar
• Griffin, O. Hayden. 2018. “Examining the Therapeutic Potential of Kratom within the American Drug Regulatory System.” Pp. 71–85 in Plant Medicines, Healing and Psychedelic Science: Cultural Perspectives, edited by B.C. Labate and C. Cavnar. New York, NY: Springer.
   Google Scholar
• Griffin, O. Hayden, Jace A. Daniels, and Elizabeth A. Gardner. 2016. “Do You Get What You Paid For? an Examination of Products Advertised as Kratom.” Journal of Psychoactive Drugs 48 (5):330–35. doi: 10.1080/02791072.2016.1229876.
   PubMed Web of Science ®Google Scholar
• Griffin, O. Hayden, Alexis Lynn Fritsch, Vanessa H. Woodward, and Richard S. Mohn. 2013. “Sifting through the Hyperbole: One Hundred Years of Marijuana Coverage in the New York Times.” Deviant Behavior 34 (10):767–81. doi: 10.1080/01639625.2013.766548.
   Web of Science ®Google Scholar
• Griffin, O.Hayden and Megan Webb. 2018. “The Scheduling of Kratom and Selective Use of Data.” Journal of Psychoactive Drugs 50 (5):1–7. doi: 10.1080/02791072.2017.1371363.
   Google Scholar
• Grundmann, Oliver. 2017. “Patterns of Kratom Use and Health Impact in the U.S.: Results from an Online Survey.” Drug and Alcohol Dependence 176 (1):63–70. doi: 10.1016/j.drugalcdep.2017.03.007.
   PubMedGoogle Scholar
• Hadley, Greg. 2016. “What Made the DEA Change its Mind about Banning a Drug for Heroin Addiction?” Miami Herald. https://www.miamiherald.com/news/nation-world/national/article107741147.html.
   Google Scholar
• Hassan, Zurina, Mustapha Muzaimi, Nurul H. Visweswaran Navaratnam, M. Yusoff, Farah W. Suhaimi, Balasingam K. Rajakumar Vadivelu, Davide Amato Vicknasingam, Stephan von Hörsten, I. W. Nurul, Nanthini Jayabalan Ismail, et al. 2013. “From Kratom to Mitragynine and Its Derivatives: Physiological and Behavioural Effects Related to Use, Abuse, and Addiction.” Neuroscience & Biobehavioral Reviews 37 (2):138–51. doi: 10.1016/j.neubiorev.2012.11.012.
   PubMed Web of Science ®Google Scholar
• Hawdon, James E. 2001. “The Role of Presidential Rhetoric in the Creation of a Moral Panic: Reagan, Bush, and the War on Drugs.” Deviant Behavior 22 (5):419–45. doi: 10.1080/01639620152472813.
   Web of Science ®Google Scholar
• Horsley, Mark. 2017.“Forget ‘Moral Panics’.”Journal of Theoretical and Philosophical Criminology 9(2): 84-98.
   Google Scholar
• Jansen, Karl L.R. and Colin J. Prast. 1988. “Psychoactive Properties of Mitragynine (Kratom).” Journal of Psychoactive Drugs 20 (4):455–57. doi: 10.1080/02791072.1988.10472519.
   PubMed Web of Science ®Google Scholar
• Jefferson, David J. 2007. “Meth: America’s Most Dangerous Drug.” Newsweek, 1–4.
   Google Scholar
• Jenkins, Phillip. 1994. “The Ice Age: The Social Construction of a Drug Panic.” Justice Quarterly 11 (1):7–31. doi: 10.1080/07418829400092111.
   Google Scholar
• Jenkins, Phillip. 1999. Synthetic Panics: The Symbolic Politics of Designer Drugs. New York: New York University Press.
   Google Scholar
• Kerley, Kent R., Heith Copes, and O. Hayden Griffin. 2015. “Middle-Class Motives for Non-Medical Prescription Stimulant Use among College Students.” Deviant Behavior 36 (7):589–603. doi: 10.1080/01639625.2014.951573.
   Web of Science ®Google Scholar
• Kronstrand, Robert, Markus Roman, Gunilla Thelander, and Anders Eriksson. 2011. “Unintentional Fatal Intoxications with Mitragynine and O-Desmethyltramadol from the Herbal Blend Krypton.” Journal of Analytical Toxicology 35 (4):242–47.
   PubMed Web of Science ®Google Scholar
• Linnemann, Travis. 2010. “Mad Men, Meth Moms, Moral Panics: Gendering Meth Crimes in the Midwest.” Critical Criminology 18 (2):95–110.
   Web of Science ®Google Scholar
• Maher, Lisa. 1992. “Reconstructing the Female Criminal: Women and Crack Cocaine.” University of Southern California Review of Law and Women’s Studies 2 (1):131–54.
   Google Scholar
• Miller, Bryan Lee, John M. Stogner, Laura E. Agnich, Amber Sanders, Joseph Bacot, and Shanna Felix. 2015. “Marketing a Panic: Media Coverage of Novel Psychoactive Drugs (Npds) and Its Relationship with Legal Changes.” American Journal of Criminal Justice 40 (3):523–41. doi: 10.1007/s12103-014-9270-6.
   Web of Science ®Google Scholar
• Montana Meth Project. 2009. http://www.montanameth.org/
   Google Scholar
• Murji, Karim. 1998. “The Agony and the Ecstasy: Drugs, Media and Morality.” Pp. 69–85 in The Control of Drugs and Drug Users: Reason or Reaction? edited by R. Coomber. Amsterdam: Harwood Academic Publishers.
   Google Scholar
• Musto, David F. 1999. The American Disease: Origins of Narcotic Control. 3rd ed. New York: Oxford University Press.
   Google Scholar
• Nelsen, Jamie L., Lapoint J, Hodgman MJ, and Kenneth M. Aldous. 2010. “Seizure and Coma following Kratom (Mitragyna Specios Korth) Exposure.” Journal of Medical Toxicology 6 (4):424–26. doi: 10.1007/s13181-010-0079-5.
   PubMedGoogle Scholar
• Powell, David, Rosalie Liccardo Pacula, and Mireille Jacobson. 2018. “Do Medical Marijuana Laws Reduce Addictions and Deaths Related to Pain Killers?” Journal of Health Economics 58 (2018):29–42. doi: 10.1016/j.jhealeco.2017.12.007.
   PubMedGoogle Scholar
• Reinarman, Craig and Harry G. Levine. 1997. “The Crack Attack: Politics and Media in the Crack Scare.” Pp. 18–51 in Crack in America: Demon Drugs and Social Justice, edited by C. Reinarman and H.G. Levine. Berkeley: University of California.
   Google Scholar
• Rosenbaum, Christopher D., Stephanie P. Carreiro, and Kavita M. Babu. 2012. “Here Today, Gone Tomorrow…And Back Again? A Review of Herbal Marijuana Alternatives (K2, Spice), Synthetic Cathinones (Bath Salts), Kratom, Salvia Divinorum, Methoxetamine, and Piperazines.” Journal of Medical Toxicology 8 (1):15–32. doi: 10.1007/s13181-011-0202-2.
   PubMedGoogle Scholar
• Singh, Darshan, Christian. P. Müller, and Balasingam Vicknasingam. 2014. “Kratom (Mitragyna Speciosa) Dependence, Withdrawal Symptoms and Craving in Regular Users.” Drug and Alcohol Dependence 139:132–37. doi: 10.1016/j.drugalcdep.2014.03.017.
   PubMed Web of Science ®Google Scholar
• Smith, Kirsten Elin and Thomas Lawson. 2017. “Prevalence and Motivations for Kratom Use in a Sample of Substance Users Enrolled in a Residential Treatment Program.” Drug and Alcohol Dependence 180 (2017):340–48. doi: 10.1016/j.drugalcdep.2017.08.034.
   PubMedGoogle Scholar
• Stogner, John and Brian Lee Miller. 2013. “Investigating the Bath Salt Panic: The Rarity of Synthetic Cathinone Use among Students in the United States.” Drug and Alcohol Review 32 (5):545–49. doi: 10.1111/dar.12055.
   PubMed Web of Science ®Google Scholar
• Taylor, Stuart. 2008. “Outside the Outsiders: Media Representations of Drug Use.” The Journal of Community and Criminal Justice 55 (4):369–87.
   Google Scholar
• Young, Jock. 1971. The Drugtakers: The Social Meaning of Drug Use. London: McGibbon and Kee.
   Google Scholar